AMYOTROPHIC-LATERAL-SCLEROSIS IS A MULTIFACTORIAL DISEASE

被引:92
|
作者
EISEN, A [1 ]
机构
[1] UNIV BRITISH COLUMBIA, VANCOUVER, BC, CANADA
关键词
AMYOTROPHIC LATERAL SCLEROSIS; PATHOGENESIS; MULTIFACTORIAL; EXCITOTOXICITY; CORTICOMOTONEURON;
D O I
10.1002/mus.880180711
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is probably biphasic. An initial trigger(s) is followed by a terminal cascade coinciding with the onset of neurological deficits. The terminal cascade involves interactive multifactorial pathogenic mechanisms. Aging must play a crucial role leading to multiple defective or degraded gene products accumulating with progressing years. This in turn leads to failure of receptor integrity and resulting excitotoxicity, free radical accumulation, failure of neurotrophism, and possibly immunological disturbances. These events are predated by months or years by a trigger which is also likely to be multifactorial and cumulative. Evidence suggests that environmental factors may be important triggers. Failure of specific glutamate transporters and calcium binding proteins may account for selective vulnerability of the corticomotoneuronal system. It is postulated that in ALS the primary target cell is the corticomotoneuron or the local circuit interneurons which modulate its activity. Glia cells may play an important role in the demise of the corticomotoneuronal cell. The disordered corticomotoneuron induces excessive excitatory transmitter (glutamate?) release at the corticomotoneuronal-spinal-motoneuronal synapse resulting in the subsequent demise of this neuron. (C) 1995 John Wiley and Sons, Inc.
引用
收藏
页码:741 / 752
页数:12
相关论文
共 50 条
  • [41] A PROGNOSTIC INDEX FOR AMYOTROPHIC-LATERAL-SCLEROSIS
    DONNENFELD, H
    GRUNDMAN, M
    HAUSER, WA
    MASDEU, JC
    ANNALS OF NEUROLOGY, 1991, 30 (02) : 255 - 256
  • [42] THERAPEUTIC TRIALS IN AMYOTROPHIC-LATERAL-SCLEROSIS
    POTES, E
    CHERRY, S
    HOFFMAN, PM
    MAYER, RF
    MUSCLE & NERVE, 1986, 9 (05) : 106 - 106
  • [43] NEUROPSYCHOLOGICAL FUNCTIONING IN AMYOTROPHIC-LATERAL-SCLEROSIS
    MASSMAN, PJ
    SIMS, J
    APPEL, SH
    COOKE, N
    NEUROLOGY, 1995, 45 (04) : A318 - A318
  • [44] EVIDENCE FOR AUTOIMMUNITY IN AMYOTROPHIC-LATERAL-SCLEROSIS
    APPEL, SH
    SMITH, RG
    ENGELHARDT, JI
    STEFANI, E
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 118 (02) : 169 - 174
  • [45] IMMUNOLOGICAL FINDINGS IN AMYOTROPHIC-LATERAL-SCLEROSIS
    ANTEL, JP
    CASHMAN, NR
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1995, 17 (01): : 17 - 28
  • [46] OCULAR ABNORMALITIES IN AMYOTROPHIC-LATERAL-SCLEROSIS
    OHKI, M
    KANAYAMA, R
    NAKAMURA, T
    OKUYAMA, T
    KIMURA, Y
    KOIKE, Y
    ACTA OTO-LARYNGOLOGICA, 1994, : 138 - 142
  • [47] ROLE OF ELECTROMYOGRAPHY IN AMYOTROPHIC-LATERAL-SCLEROSIS
    BEHNIA, M
    KELLY, JJ
    MUSCLE & NERVE, 1991, 14 (12) : 1236 - 1241
  • [48] AMYOTROPHIC-LATERAL-SCLEROSIS AND POLIO - IS THERE AN ASSOCIATION
    OKUMURA, H
    KURLAND, LT
    WARING, SC
    POST-POLIO SYNDROME: ADVANCES IN THE PATHOGENESIS AND TREATMENT, 1995, 753 : 245 - 256
  • [49] RESPIRATORY DYSFUNCTION IN AMYOTROPHIC-LATERAL-SCLEROSIS
    KAPLAN, LM
    HOLLANDER, D
    CLINICS IN CHEST MEDICINE, 1994, 15 (04) : 675 - 681
  • [50] PATHOPHYSIOLOGY OF FATIGUE IN AMYOTROPHIC-LATERAL-SCLEROSIS
    SHARMA, KR
    KENTBRAUN, J
    MAJUMDAR, S
    MYNHIER, M
    WEINER, M
    MILLER, RG
    NEUROLOGY, 1993, 43 (04) : A256 - A257